Mechanisms of genotoxin-induced transcription and hypermutation in p53

Cancer Cell International

Volumn 6, Issue , 2006, Pages

  Wright, Barbara ^a   Reimers, Jacqueline ^a   Schmidt, Karen ^a   Burkala, Evan ^a   Davis, Nick ^a   Wei, Ping ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOTOXIN; PROTEIN P53; SINGLE STRANDED DNA; TOXIN;

ARTICLE; BASE PAIRING; CANCER; CARCINOGENESIS; COLON CANCER; COMPUTER PROGRAM; DNA DAMAGE; DNA STRUCTURE; GENE MUTATION; GENOTOXICITY; LUNG CANCER; MOLECULAR STABILITY; MUTATION RATE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; STRESS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 33845811475     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-6-27     Document Type: Article

References (32)

1. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990, 249(4971):912-915.
2. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992, 71(4):587-597.
3. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 1991, 351(6326):453-456
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253(5015):49-53.
5. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994, 14(3):1815-1823.
6. Pfeifer GP: p53 mutational spectra and the role of methylated CpG sequences. Mutat Res 2000, 450(1-2):155-166.
7. Rodin SN, Rodin AS: Origins and selection of p53 mutations in lung carcinogenesis. Semin Cancer Biol 2005, 15(2):103-112.
8. Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang M, Pfeifer GP: Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 2000, 92(10):803-11.
9. Amundson SA, Do KT, Vinikoor L, Koch-Paiz CA, Bittner ML, Trent JM, Meltzer P, Fornace AJ Jr.: Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene 2005, 24(28):4572-4579.
10. Wright BE, Longacre A, Reimers JM: Hypermutation in derepressed operons of Escherichia coli K-12. Proc Natl Acad Sci U S A 1999, 96(9):5089-5094.
11. Wright BE, Reschke DK, Schmidt KH, Reimers JM, Knight W: Predicting mutation frequencies in stem-loop structures of derepressed genes: implications for evolution. Mol Microbiol 2003, 48(2):429-441.
12. Wright BE: A biochemical mechanism for nonrandom mutations and evolution. J Bacteriol 2000, 182(11):2993-3001.
13. Wright BE: Stress-directed adaptive mutations and evolution. Mol Microbiol 2004, 52(3):643-650.
14. Reimers JM, Schmidt KH, Longacre A, Reschke DK, Wright BE: Increased transcription rates correlate with increased reversion rates in leuB and argH Escherichia coil auxotrophs. Microbiology 2004, 150(Pt 5): 1457-1466.
15. Schmidt KH, Reimers JM, Wright BE: The effect of promoter strength, supercoiling and secondary structure on mutation rates in Escherichia coli. Mol Microbiol 2006, 60(5):1251-1261.
16. Ghosh R, Mitchell DL: Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucleic Acids Res 1999, 27(15):3213-3218.
17. Wright BE, Reimers JM, Schmidt KH, Reschke DK: Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures. Cancer Res 2002, 62(20):5641-5644.
18. Bachl J, Carlson C, Gray-Schopfer V, Dessing M, Olsson C: Increased transcription levels induce higher mutation rates in a hypermutating cell line. J Immunol 2001, 166(8):5051-5057.
19. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G: Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1994, 174(1):23-31.
20. Parenti AR, Rugge M, Frizzera E, Ruol A, Noventa F, Ancona E, Ninfo V: p53 overexpression in the multistep process of esophageal carcinogenesis. Am J Surg Pathol 1995, 19(12):1418-1422.
21. Sun X, Shimizu H, Yamamoto K: Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. Mol Cell Biol 1995, 15(8):4489-4496.
22. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N: Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity. J Biol Chem 1999, 274(49):35240-35246.
23. Kroncke KD: Nitrosative stress and transcription. Biol Chem 2003, 384(10-11):1365-1377.
24. Wu H, Lozano G: NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994, 269(31):20067-20074.
25. Liu LF, Wang JC: Supercoiling of the DNA template during transcription. Proc Natl Acad Sci U S A 1987, 84(20):7024-7027.
26. Lindahl T: Instability and decay of the primary structure of DNA. Nature 1993, 362(6422):709-715.
27. Singer B, Kusmierek JT: Chemical mutagenesis. Annu Rev Biochem 1982, 51:655-693.
28. Cooper DN, Youssoufian H: The CpG dinucleotide and human genetic disease. Hum Genet 1988, 78(2):151-155.
29. Dayn A, Malkhosyan S, Mirkin SM: Transcriptionally driven cruciform formation in vivo. Nucleic Acids Res 1992, 20:5991-5997.
30. Krasilnikov AS, Podtelezhnikov A, Vologodskii A, Mirkin SM: Large-scale effects of transcriptional DNA supercoiling in vivo. J Mol Biol 1999, 292(5):1149-1160.
31. The IARC TP53 Mutation Database [http://www-p53.iarc.fr/]
32. Hernandez-Boussard T, Rodriguez-Tome P, Montesano R, Hainaut P: IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer. Hum Mutat 1999, 14(1):1-8.